Issy les Joulineaux, France

Ve/ Ronique Comazzi

This inventor holds 1 USPTO granted patent. Top assignee: Cis Bio International. Active years: 1996.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ve/ Ronique Comazzi: Innovator in Radiopharmaceuticals

Introduction

Ve/ Ronique Comazzi is a prominent inventor based in Issy les Moulineaux, France. She has made significant contributions to the field of radiopharmaceuticals, particularly with her innovative work that focuses on cerebral tropism. Her dedication to advancing medical technology has led to the development of a unique patent that addresses critical health needs.

Latest Patents

Ve/ Ronique Comazzi holds a patent for a radiopharmaceutical product that has specific applications in targeting cerebral areas. This invention is crucial for enhancing diagnostic and therapeutic procedures in neurology. The patent showcases her expertise and commitment to improving patient outcomes through innovative solutions. She has 1 patent to her name.

Career Highlights

Comazzi is currently employed at Cis Bio International, a company known for its advancements in the field of radiopharmaceuticals. Her role at Cis Bio International allows her to collaborate with other experts in the industry and contribute to groundbreaking research and development projects.

Collaborations

Throughout her career, Ve/ Ronique Comazzi has worked alongside notable colleagues, including Roberto Pasqualini and Emmanuel Bellande. These collaborations have enriched her work and fostered an environment of innovation and creativity.

Conclusion

Ve/ Ronique Comazzi is a trailblazer in the field of radiopharmaceuticals, with a focus on cerebral applications. Her contributions through her patent and work at Cis Bio International highlight her commitment to advancing medical technology. Her innovative spirit continues to inspire others in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…